Systemic effects of oral tolerance on inflammation: mobilization of lymphocytes and bone marrow eosinopoiesis.
Oral tolerance is a T-cell mediated phenomenon defined by inhibition of immune responsiveness to a protein previously contacted by the oral route. Oral tolerance may prevent autoimmune and allergic diseases that involve the recruitment and/or activation of different cell types including mast cells, neutrophils, eosinophils, monocytes and lymphocytes. The mechanisms by which oral tolerance avoids these immunological disorders are still controversial. Herein we used a murine model of ovalbumin (OVA)-induced peritonitis to investigate the effect of oral tolerance on allergic inflammation. Frequency of leucocyte subpopulations was evaluated by global and differential cell counts in peritoneal lavage fluid, peripheral blood, and bone marrow. Changes on lymphocyte subsets and adhesion molecules expression by these cells were analysed by flow cytometry. As compared with OVA-immune mice, intraperitoneal challenge of tolerant animals with OVA resulted in a significantly milder peritonitis, mostly affecting neutrophils and eosinophils; a concomitant reduction in total white blood cell counts was also observed, mainly because of lower neutrophil and eosinophil counts. Eosinophils, but not neutrophils, were also reduced in the bone-marrow of OVA-challenged tolerant mice. No changes occurred in total peritoneal lymphocyte counts in OVA-tolerant mice, however, there was a significant decrease in CD3+ CD8+ T cells and an increase in B cells (CD45R+) in these animals as compared to immune OVA-challenged animals. Altered expression of CD18 and CD54, respectively, in blood and peritoneal lymphocytes was also noted. These results suggest that, in addition to local specific effects, oral tolerance has systemic effects on the mobilization of leucocytes and bone-marrow eosinopoiesis.
Rodrigues
Claudiney M
CM
Departmentos de Morfologia, ICB-Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Martins-Filho
Olindo A
OA
Vaz
Nelson M
NM
Carvalho
Cláudia R
CR
D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000276:immunology; D001202:Ascitic Fluid / Q000276:immunology; D001853:Bone Marrow / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000378:metabolism; D004802:Eosinophilia / Q000517:prevention & control; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006098:Granulocytes / Q000276:immunology; D006967:Hypersensitivity / Q000276:immunology*; D007108:Immune Tolerance / Q000276:immunology*; D007958:Leukocyte Count; D016131:Lymphocyte Subsets / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D009504:Neutrophils / Q000276:immunology; D010047:Ovalbumin / Q000008:administration & dosage; D010538:Peritonitis / Q000276:immunology*
D000941:Antigens; D015815:Cell Adhesion Molecules; D010047:Ovalbumin